Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

commercial cannabis

  • Home
  •  
  • commercial cannabis



  • Most Read
  • Latest Comments
  • Althea becomes first Aussie cannabis company to be licensed in Germany
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Althea becomes first Aussie cannabis company to be licensed in Germany
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Althea becomes first Aussie cannabis company to be licensed in Germany
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Althea becomes first Aussie cannabis company to be licensed in Germany
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Althea becomes first Aussie cannabis company to be licensed in Germany
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

  • Melodiol moves to clear debt with $12m asset fire sale
    Melodiol moves to clear debt with $12m asset fire sale
    • News

  • Althea to make a splash in the US with new cannabis-based sodas
    Althea to make a splash in the US with new cannabis-based sodas
    • News

  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

  • Wellnex ventures into medicinal cannabis with it’s new Wellness Life brand
    Wellnex ventures into medicinal cannabis with it’s new Wellness Life brand
    • News

  • Althea becomes first Aussie cannabis company to be licensed in Germany
    • News

    Althea becomes first Aussie cannabis company to be licensed in Germany

    Medicinal cannabis and research company Althea Group (ASX: AGH) has become the first Australian producer of commercial cannabis products to be granted the required licenses in Germany for sales and distribution. With the licences, Althea expects their first shipment of their Australian-made medicinal cannabis extract products to take place in December 2020. The licenses were

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.